ArticleCureus2026
Dexmedetomidine vs. Propofol-Fentanyl for Bispectral Index (BIS)-Guided Sedation During Awake Fiberoptic Intubation in Neurosurgical Patients With Anticipated Difficult Airways: An Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Awake fiberoptic intubation (AFOI) is commonly employed in neurosurgical patients with anticipated difficult airways to minimize spinal cord compression and intracranial pressure fluctuations, although procedural discomfort remains a major limitation. This prospective observational study evaluated the AFOI with two commonly used conscious sedation regimens-dexmedetomidine and a propofol-fentanyl combination-guided by Bispectral Index (BIS) and the Observer's Assessment of Alertness/Sedation (OAA/S) scale, along with spray-as-you-go (SAYGO) topical anesthesia. Outcomes assessed included AFOI conditions - cough severity and intubation conditions; time to achieve target sedation (BIS value of 70); hemodynamic changes; total intubating attempts; intubation time; correlation between BIS and OAA/S; perioperative complications; and postoperative recall. Methods Forty consecutive adult patients undergoing AFOI for elective neurosurgical procedures received conscious sedation with either dexmedetomidine (Group D) or propofol-fentanyl (Group PF) as part of routine clinical practice. Conscious sedation was titrated using BIS, and the corresponding OAA/S scores were assessed. Airway topicalization was achieved using the SAYGO technique. Results Patients receiving propofol-fentanyl demonstrated superior intubation conditions compared with dexmedetomidine, as evidenced by higher total intubation scores (7.80 ± 0.62 vs. 7.11 ± 1.24; p = 0.039) and shorter intubation times (16.10 ± 10.95 vs. 27.79 ± 21.18 seconds; p = 0.036). Additionally, the propofol-fentanyl group also exhibited less coughing, better endotracheal tube tolerance, lower lignocaine requirements, and improved postoperative recovery profile with fewer complaints of sore throat during the first 48 hours after surgery. Procedure recall was absent in both groups. Conclusion In routine clinical practice, BIS-guided conscious sedation with a propofol-fentanyl combination was associated with better intubating conditions and procedural tolerance than dexmedetomidine during AFOI in high-risk neurosurgical patients. The SAYGO technique further enhanced patient comfort and safety, providing a practical alternative to conventional airway nerve blocks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.